Likes Subject
Effective Dec. 23,2022 GNCA will change to GNCAQ, bankruptcy. Renee 12/22/22 9:34 AM
Comeback time MVick 11/10/22 6:53 PM
DTIL covers with better money and partners similar swampboots 08/03/22 12:32 PM
The collab is focused on advancing multiple existing jondoeuk 08/03/22 12:21 PM
PSTX swampboots 08/03/22 10:30 AM
$62M in valuation, assets and cash, and selling Milo1 06/22/22 10:04 PM
GNCA featured in Microcapdaily : https://microcapdaily.com/genocea-biosciences-i JDCruz 06/15/22 12:19 PM
It means whatever was in the S-8 has Renee 06/08/22 9:34 PM
What does notice of effectiveness mean? Wisebuys 06/08/22 1:09 PM
This is starting to tick back up now..... cparma 06/06/22 11:29 AM
GNCA delisted from the Nasdaq to the OTC: Renee 06/03/22 5:18 PM
Not sure about Fraud. They just went out cparma 06/03/22 9:54 AM
Plain and simple - FRAUD!!!!! ErnieBilco 05/24/22 10:09 AM
Fraud!! NY1972 05/24/22 10:06 AM
Leerink Partners should feel pretty stupid right about now. ErnieBilco 05/24/22 8:39 AM
Ouch Awl416 05/24/22 8:30 AM
Preclinical posters jondoeuk 05/19/22 5:09 PM
ATLAS worked. Planet failed. NY1972 05/16/22 5:20 PM
PR https://www.prnewswire.com/news-releases/pact-pharma-highlights-capabilities- jondoeuk 05/16/22 12:37 PM
''NT-125 is an investigational, autologous, fully-individualized, multi-specif jondoeuk 05/10/22 1:23 PM
189: A Versatile, Non-Viral Gene Editing Method for jondoeuk 05/02/22 5:02 PM
Hopefully, this will play out similar to MRK jondoeuk 04/29/22 8:15 PM
Biotechs are filled with frauds. Investors kept in NY1972 04/28/22 7:08 PM
CEO knew Planet failed when DP was made NY1972 04/28/22 6:58 PM
NPT turned out to be a lost TIL. NY1972 04/28/22 6:10 PM
Turnstone Bio https://www.businesswire.com/news/home/20220425005377/en/Turnstone jondoeuk 04/27/22 7:18 PM
By Q4 (GEN-011) jondoeuk 04/27/22 7:14 PM
From this: ''Using high-dimensional analysis of human ACT jondoeuk 04/27/22 4:38 PM
young” tumor infiltrating lymphocytes can mediate regression of NY1972 04/27/22 1:20 PM
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors NY1972 04/26/22 8:59 PM
Intratumoral CD40 agonist sotigalimab with pembrolizumab induces broad NY1972 04/25/22 9:19 PM
Mellman described published work linking PD-1 and CD28 NY1972 04/25/22 9:10 PM
Bio chop suey :-): Orca-T is an investigational NY1972 04/25/22 10:25 AM
The poster jondoeuk 04/24/22 3:33 PM
Speaking of GvHD, Orca Bio (an IPO could jondoeuk 04/24/22 2:01 PM
Some slides from a presentation given at ESMO jondoeuk 04/24/22 1:55 PM
High-Dose Cyclophosphamide Reduces Graft-Versus-Host Disease Following Stem Cell NY1972 04/23/22 10:47 PM
Emergence of tumor mismatch repair deficiency and increased NY1972 04/23/22 10:21 PM
The reason high-dose cyclophosphamide is able to ablate NY1972 04/23/22 10:05 PM
NeoPhore is developing first-in-class small molecule inhibitors to jondoeuk 04/23/22 6:56 PM
Fludarabine exposure predicts outcome after CD19 CAR T-cell NY1972 04/22/22 9:21 PM
MC = 64 doses CAR T NY1972 04/22/22 9:53 AM
T cells CPD NY1972 04/21/22 8:24 PM
GNCA Buyers and sellers feel like TILS :-) NY1972 04/21/22 6:31 PM
Last Smart Money left the bldg. only dummies NY1972 04/21/22 10:37 AM
Analysis of severe lymphodepletion on the day of NY1972 04/20/22 8:35 PM
Cyclophosphamide alters the tumor cell secretome to potentiate NY1972 04/20/22 4:15 PM
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant NY1972 04/20/22 4:05 PM
The effect of low-dose IL-2 and Treg adoptive NY1972 04/19/22 11:32 PM
A PhI trial (NCT04217473) is assessing an 'armed' jondoeuk 04/17/22 4:58 PM
Likes Subject

MVick
11/10/22 6:53 PM
swampboots
08/03/22 10:30 AM
Renee
06/08/22 9:34 PM
Wisebuys
06/08/22 1:09 PM
ErnieBilco
05/24/22 10:09 AM
NY1972
05/24/22 10:06 AM
Awl416
05/24/22 8:30 AM
jondoeuk
05/19/22 5:09 PM
NY1972
05/16/22 5:20 PM
NY1972
04/28/22 6:58 PM
NY1972
04/28/22 6:10 PM
jondoeuk
04/27/22 7:14 PM
jondoeuk
04/24/22 3:33 PM
jondoeuk
04/24/22 2:01 PM
NY1972
04/22/22 9:53 AM
NY1972
04/21/22 8:24 PM

Genocea Biosciences Inc. (GNCAQ)

Followers
30
Posters
113
Posts (Today)
0
Posts (Total)
932
Created
06/13/15
Type
Free
Moderators
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
GNCAQ Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post